Moderna (MRNA) Amortizatization of Intangibles (2018 - 2026)

Moderna (MRNA) has 9 years of Amortizatization of Intangibles data on file, last reported at $11.0 million in Q1 2026.

• Amortizatization of Intangibles for Q1 2026 came in at $11.0 million, down 42.11% year-over-year; the trailing twelve-month figure through Mar 2026 was $59.0 million (down 32.18% YoY), and the FY2025 annual result was $67.0 million, down 29.47% from the prior year.
• Amortizatization of Intangibles eased to $11.0 million in Q1 2026 per MRNA's latest filing, from $13.0 million in the prior quarter.
• Over five years, Amortizatization of Intangibles peaked at $28.0 million in Q2 2024 and troughed at -$18.0 million in Q1 2022.
• A 5-year average of $11.9 million and a median of $17.0 million in 2023 frame the typical range for Amortizatization of Intangibles.
• The sharpest annual moves came in 2022 and 2023: Amortizatization of Intangibles plunged 260.0% in 2022, then surged 400.0% in 2023.
• A 5-year view of Amortizatization of Intangibles shows it stood at $4.0 million in 2022, then surged by 400.0% to $20.0 million in 2023, then declined by 5.0% to $19.0 million in 2024, then sank by 31.58% to $13.0 million in 2025, then retreated by 15.38% to $11.0 million in 2026.
• Business Quant data shows MRNA's Amortizatization of Intangibles at $11.0 million in Q1 2026, $13.0 million in Q4 2025, and $17.0 million in Q3 2025.